GSK and Dr. Reddy’s Agree To Product Development And Marketing Alliance

LONDON — GlaxoSmithKline PLC said Monday it had reached a deal with Indian drug developer Dr. Reddy’s Laboratories Ltd. to develop and market selected products across many emerging markets.

London-based Glaxo did not reveal terms of the deal, which is effective immediately but excludes India.

Under the agreement, Glaxo will gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.
http://www.pharmpro.com/ShowPR.aspx?PUBCODE=021&ACCT=0000100&ISSUE=0906&RELTYPE=IN&PRODCODE=0000&PRODLETT=DH&CommonCount=0

This entry was posted on Tuesday, June 16th, 2009 at 6:24 am and is filed under Healthcare & Pharma. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

2 Comments

  1. christopher says:
    January 21, 2015 at 1:50 am

    Gerard says:

    January 21, 2015 at 3:32 am

    July 2015

  2. September 2014
  3. August 2014
  4. July 2014
  5. April 2014
  6. September 2013
  7. March 2013
  8. February 2013
  9. July 2012
  10. January 2012
  11. December 2011
  12. November 2011
  13. August 2011
  14. April 2011
  15. March 2011
  16. February 2011
  17. January 2011
  18. December 2010
  19. November 2010
  20. October 2010
  21. September 2010
  22. August 2010
  23. July 2010
  24. June 2010
  25. May 2010
  26. April 2010
  27. March 2010
  28. February 2010
  29. January 2010
  30. December 2009
  31. November 2009
  32. October 2009
  33. September 2009
  34. August 2009
  35. July 2009
  36. June 2009
  37. May 2009

  38. Tag Bag

  39. Tag Cloud

  40. Twitter Feed

    Posting tweet...